We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.09B
AUM Growth
+$1.38B
Cap. Flow
+$926M
Cap. Flow %
18.19%
Top 10 Hldgs %
35.13%
Holding
112
New
25
Increased
38
Reduced
18
Closed
24

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$137M
2
AGN.PRA
Allergan plc
AGN.PRA
+$89.2M
3
CNC icon
Centene
CNC
+$76.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$57.1M
5
JD icon
JD.com
JD
+$52M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$243M
2
UHS icon
Universal Health Services
UHS
+$91.1M
3
PCRX icon
Pacira BioSciences
PCRX
+$87.8M
4
MCK icon
McKesson
MCK
+$72.1M
5
BABA icon
Alibaba
BABA
+$54.9M

Sector Composition

Rank Sector Weight
1 Healthcare 33.12%
2 Technology 12.48%
3 Communication Services 5.27%
4 Consumer Discretionary 4.56%
5 Financials 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NITE
76
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$9.88M 0.19%
+514,427
New +$11.1M
PRAH
77
DELISTED
PRA Health Sciences, Inc.
PRAH
$8.63M 0.17%
+113,283
New +$8.56M
IVTY
78
DELISTED
Invuity, Inc
IVTY
$8.27M 0.16%
929,293
+477,532
+106% +$3.64M
VYGR icon
79
Voyager Therapeutics
VYGR
$187M
$8.19M 0.16%
397,923
-455,202
-53% -$5.14M
CMTA
80
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$5.7M 0.11%
+337,201
New +$5.51M
KITE
81
DELISTED
Kite Pharma, Inc.
KITE
$529K 0.01%
2,944
-1,740,407
-100% -$243M
AGN
82
DELISTED
Allergan plc
AGN
$88K ﹤0.01%
+428
New +$99.5K
COUP
83
DELISTED
Coupa Software Incorporated
COUP
$60K ﹤0.01%
+1,937
New +$59.1K
AAPL icon
84
Apple
AAPL
$4.89T
– –
-535,232
Closed -$19.3M
AMT icon
85
American Tower
AMT
$77.7B
– –
-228,350
Closed -$30.2M
BIIB icon
86
Biogen
BIIB
$29.9B
– –
-4,046
Closed -$1.1M
BKNG icon
87
Booking.com
BKNG
$138B
– –
-198,875
Closed -$14.9M
BMRN icon
88
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-153,018
Closed -$13.9M
BTU icon
89
Peabody Energy
BTU
$2.78B
– –
-122,101
Closed -$2.98M
CHRS icon
90
CALL
Coherus Oncology
CHRS
$217M
– –
-62,400
Closed -$895K
CHRS icon
91
Coherus Oncology
CHRS
$217M
– –
-1,802,611
Closed -$25.9M
HRTX icon
92
Heron Therapeutics
HRTX
$86.3M
– –
-3,344,517
Closed -$46.3M
IWM icon
93
PUT
iShares Russell 2000 ETF
IWM
$79.8B
– –
-37,800
Closed -$5.33M
LBTYA icon
94
Liberty Global Class A
LBTYA
$3.31B
– –
-1,155,765
Closed -$37.1M
MCK icon
95
McKesson
MCK
$98.5B
– –
-438,055
Closed -$72.1M
MRVL icon
96
Marvell Technology
MRVL
$174B
– –
-1,205,837
Closed -$19.9M
PBYI icon
97
CALL
Puma Biotechnology
PBYI
$406M
– –
-309,100
Closed -$27M
PCRX icon
98
Pacira BioSciences
PCRX
$1.02B
– –
-1,840,618
Closed -$87.8M
RGNX icon
99
Regenxbio
RGNX
$623M
– –
-271,603
Closed -$5.36M
UHS icon
100
Universal Health Services
UHS
$9.43B
– –
-746,051
Closed -$91.1M
1 2 3
4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2017 Portfolio in Review

As of Q3 2017, PFM Health Sciences held 112 positions worth $5.09B, up 37% from $3.71B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences deployed $926M of net new capital in Q3 2017, opening 25 new positions and adding to 38 existing holdings. Its largest new stake was Allergan plc: 107,410 shares worth $79.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $243M trimmed.

  • PFM Health Sciences's largest Q3 2017 buy was Allergan plc: 107,410 shares worth $79.2M.
  • PFM Health Sciences added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $137M increase.
  • PFM Health Sciences's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $243M.
  • PFM Health Sciences fully exited Universal Health Services in Q3 2017, selling an estimated $91.1M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $5.09B portfolio in Q3 2017.
  • PFM Health Sciences opened 25 new positions and closed 24 in Q3 2017.
  • PFM Health Sciences's portfolio value rose 37% quarter-over-quarter to $5.09B.

Based on PFM Health Sciences's 13F filing for Q3 2017, filed 14 Nov 2017.